Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne

PHASE4CompletedINTERVENTIONAL
Enrollment

302

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Acne Vulgaris
Interventions
DRUG

Adapalene Gel, 0.1%

Apply once daily in the evening for 12 weeks

DRUG

Tazarotene Cream, 0.1%

Apply once daily in the evening for 12 weeks

DRUG

Adapalene Gel, 0.1% + Tazarotene Cream, 0.1%

Apply adapalene Gel, 0.1% once daily in the evening for 6 weeks and Tazarotene Cream, 0.1% once daily in the evening for 6 weeks

Trial Locations (12)

11203

State University of New York Downstate Medical Center-Dept. of Dermatology, Brooklyn

23507

Virginia Clinical Research, Inc., Norfolk

45230

Dermatology Research Associates, Cincinnati

48202

Henry Ford Medical Center-Dept. of Dermatology, Detroit

55432

Minnesota Clinical Study Center, Fridley

75006

Stephens & Associates, Carrollton

77802

J & S Studies, Inc., Bryan

78759

DermResearch, Inc., Austin

84124

Dermatology Research Center, Salt Lake City

92123

Therapeutics Clinical Research, San Diego

97210

Phoebe Rich, MD & Associates, Portland

17033-0850

Milton S. Hershey Medical Center Center-Div. of Dermatology, Hershey

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT00469755 - Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne | Biotech Hunter | Biotech Hunter